摘要
目的:研究居住在新加坡的马来人意识障碍和老年痴呆症的发病率,同时检测中国人和马来人在发病率中的不同。 方法:样本(大于等于60岁)-从正在进行的多种族的新加坡老年痴呆症流行病学中的马来人成分中选出,使用局部验证简易智力测试和渐进的遗忘问卷筛选。随后,筛选阳性参与者进行详细的神经心理学和神经影像学评估。无痴呆型认知障碍(CIND)和痴呆型在公认标准上被诊断。 结果:包括总的966名马来人,102名为轻度CIND,135名调节性CIND,27名老年痴呆患者。所有年龄标准中任意意识障碍发病率为25.5%,包括2%的老年痴呆患者。任意意识障碍发病率中随年龄增长中60-64岁增加14.9%,大于等于80岁增加40.2%。女人较男人有更高的CIND和老年痴呆患病率。与早年中国EDIS出版的数据相比较,马来人有接近两倍的几率患任意一种意识障碍症(比值调整年龄,人口和心血管危险因素,载脂蛋白4载体:2.03,95%可信区间:1.48 - 2.77)结论:在老年马来人中,任意意识障碍的总患病率是25.5%。尽管有相似的和调节的已知危险因素,马来人意识障碍患病率依然高于中国人。很有必要做进一步的研究,解开可能导致这些种族意识障碍发生差异的其他因素
关键词: 意识障碍,老年痴呆症,马来人,发病率,风险因素,人口基础。
Current Alzheimer Research
Title:Prevalence of Cognitive Impairment and Dementia in Malays – Epidemiology of Dementia in Singapore Study
Volume: 14 Issue: 6
关键词: 意识障碍,老年痴呆症,马来人,发病率,风险因素,人口基础。
摘要: Objective: To study the prevalence of cognitive impairment and dementia in communitydwelling Malays from Singapore; and to examine differences in prevalence among Chinese and Malays.
Methods: Subjects (≥ 60 years) - drawn from the Malay component of the on-going multiethnic Epidemiology of Dementia in Singapore study - were screened using locally validated Abbreviated Mental Test and Progressive Forgetfulness Questionnaire. Subsequently, screen-positive participants underwent detailed neuropsychological assessments and neuroimaging. Cognitive impairment no dementia (CIND) and dementia were diagnosed based on accepted criteria. Results: A total of 966 Malay subjects were included, of whom 102 had CIND-mild, 135 CINDmoderate, and 27 dementia. The overall age-standardized prevalence of any cognitive impairment was 25.5%, including 2% of dementia. The prevalence of any cognitive impairment increased with age from 14·9% in those aged 60-64 years to 40.2% in age ≥80 years. Women had a higher prevalence of CIND and dementia than men. Compared to previously published data from EDIS on Chinese, Malay were nearly twice more likely to have any cognitive impairment (Odds ratios adjusted for age, demographic and cardiovascular risk factors, and ApoEε4 carrier: 2.03, 95% confidence interval: 1.48–2.77). Conclusion: Among elderly Malays, the overall prevalence of any cognitive impairment was 25.5%. Even with a similar protocol of recruitment and assessment and adjusting for known risk factors, the prevalence of cognitive impairment was higher in Malays compared to Chinese. Further research is needed to unravel other factors that may underlie these ethnic differences in the occurrence of cognitive impairment.Export Options
About this article
Cite this article as:
Prevalence of Cognitive Impairment and Dementia in Malays – Epidemiology of Dementia in Singapore Study, Current Alzheimer Research 2017; 14 (6) . https://dx.doi.org/10.2174/1567205012666151002123813
DOI https://dx.doi.org/10.2174/1567205012666151002123813 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nuclear Imaging of Post-infarction Inflammation in Ischemic Cardiac Diseases - New Radiotracers for Potential Clinical Applications
Current Radiopharmaceuticals Platelets and Atherothrombosis: Causes, Targets and Treatments for Thrombosis
Current Medicinal Chemistry Brain Injury Associated with Widely Abused Amphetamines: Neuroinflammation, Neurogenesis and Blood-Brain Barrier
Current Drug Abuse Reviews Roles of p75NTR in Maintaining Brain Hemostasis and the Implications for p75NTR-targeted Therapies
Current Alzheimer Research Editorial: Alzheimer's Disease: From Molecular Mechanisms to Psychobiological Perspectives
Current Alzheimer Research Stroke History is an Independent Risk Factor for Poor Prognosis in Ischemic Stroke Patients: Results from a Large Nationwide Stroke Registry
Current Neurovascular Research Hypothalamic Insulin-Sensitizing Effect of Exenatide in Dietary Induced Rat Model of Obesity
Current Drug Therapy Editorial [Hot Topic:Perspective on Mild Cognitive Impairment (MCI) (Guest Editor: Bernardino Ghetti)]
Current Alzheimer Research Metal Protein Attenuating Compounds (MPACs): An Emerging Approach for the Treatment of Neurodegenerative Disorders
Current Bioactive Compounds Perispinal Etanercept for Treatment of Alzheimers Disease
Current Alzheimer Research Potential for Stem Cells Therapy in Alzheimer’s Disease: Do Neurotrophic Factors Play Critical Role?
Current Alzheimer Research Future Directions in the Treatment of Neuropathic Pain: A Review on Various Therapeutic Targets
CNS & Neurological Disorders - Drug Targets Platelet Function in Inflammatory Diseases: Insights from Clinical Studies
Inflammation & Allergy - Drug Targets (Discontinued) Mitochondrial Aconitase in Neurodegenerative Disorders: Role of a Metabolism- related Molecule in Neurodegeneration
Current Drug Targets The Phosphoinositide Signal Transduction Pathway in the Pathogenesis of Alzheimer’s Disease
Current Alzheimer Research CRISPR/Cas9 in Stem Cell Research: Current Application and Future Perspective
Current Stem Cell Research & Therapy Hippocampal BDNF Expression in a Tau Transgenic Mouse Model
Current Alzheimer Research Antioxidants and Neuroprotection in the Adult and Developing Central Nervous System
Current Medicinal Chemistry In Silico Binding Mode Proposed for Flavonoid Ligands of Tau Protein with Interest in Alzheimer's Disease
Current Bioactive Compounds Targeting Xanthine Oxidase by Natural Products as a Therapeutic Approach for Mental Disorders
Current Pharmaceutical Design